Hamburg: FDA is taking concerns over 510(k) changes seriously

10/21/2010 | (Boston)

The FDA is conducting a thorough review of the public comments and "substantive concerns" regarding its proposed changes to the 510(k) process for clearing medical devices, said Dr. Margaret Hamburg, the agency's chief. During her speech at a conference in Washington, D.C., Hamburg said the FDA will provide explanations before adopting a proposal that raised a number of significant concerns among the industry.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ